Expression of hepatocyte nuclear factor-1β in human urogenital tract during the embryonic stage

Analytical and Quantitative Cytology and Histology

Volumn 31, Issue 1, 2009, Pages 34-40

  Kato, Noriko ^a   Motoyama, Teiichi ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

Hnf l ; Mesonephric duct; Metaneph ros; Mullerian duct; Remnants

Indexed keywords

HEPATOCYTE NUCLEAR FACTOR 1BETA;

ARTICLE; EMBRYO DEVELOPMENT; EPIDIDYMIS; FEMALE; FETUS; GESTATION PERIOD; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY TUBULE; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; UROGENITAL SYSTEM; UTERINE TUBE;

ADULT; AGED; AGED, 80 AND OVER; BILE DUCTS; EMBRYO, MAMMALIAN; EPIDIDYMIS; FALLOPIAN TUBES; FEMALE; FETUS; HEPATOCYTE NUCLEAR FACTOR 1-BETA; HUMANS; KIDNEY GLOMERULUS; KIDNEY TUBULES; LIVER; MALE; MIDDLE AGED; OVARY; PANCREAS; TESTIS; UROGENITAL SYSTEM; UTERUS; WOLFFIAN DUCTS;

WOLFFIA;

EID: 61849114712     PISSN: 08846812     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Rey-Campos J, Chouard T, Yaniv M, Cereghini S: vHNFl is a homeoprotein that activates transcription and forms het-erodimers with HNF1. EMBO J 1991;10:1445-1457
2. Cereghini S, Blumenfeld M, Yaniv M: A liver-specific factor essential for albumin transcription differs between differentiated and dedifferentiated rat hepatoma cells. Genes Dev 1988;2:957-974
3. Haumaitre C, Fabre M, Cormier S, Baumann C, Delezoide AL, Cereghini S: Severe pancreas hypoplasia and multicystic renal dysplasia in two human fetuses carrying novel HNFlbeta/MODY5 mutations. Hum Mol Genet 2006;15: 2363-2375
4. Barbacci E, Reber M, Ott MO, Breillat C, Huetz F, Cereghini S: Variant hepatocyte nuclear factor 1 is required for visceral endoderm specification. Development 1999;126:4795-4805
5. Coffinier C, Thépot D, Babinet C, Yaniv M, Barra J: Essential role for the homeoprotein vHNF/HNFlbeta in visceral endoderm differentiation. Development 1999;126:4785-4794
6. Coffinier C, Barra J, Babinet C, Yaniv M: Expression of the vHNFl/HNFlbeta homeoprotein gene during mouse organogenesis. Mech Dev 1999;89:211-213
7. Reber M, Cereghini S: Variant hepatocyte nuclear factor 1 expression in the mouse genital tract. Mech Dev 2001;100:75-78
8. Horikawa Y, Iwasaki N, Hara M, Furuta H, Hinokio Y, Cock-burn BN, Lindner T, Yamagata K, Ogata M, Tomonaga O, Kuroki H, Kasahara T, Iwamoto Y, Bell GI: Mutation in hepatocyte nuclear factor-lbeta gene (TCF2) associated with MODY. Nat Genet 1997;17:384-385
9. Lindner TH, Njolstad PR, Horikawa Y, Bostad L, Bell GI, Sovik O: A novel syndrome of diabetes mellitus, renal dysfunction and genital malformation associated with a partial deletion of the pseudo-POU domain of hepatocyte nuclear factor-lbeta. Hum Mol Genet 1999;8:2001-2008
10. Bingham C, Ellard S, Cole TR, Jones KE, Allen LI, Goodship JA, Goodship TH, Bakalinova-Pugh D, Russell GI, Woolf AS, Nicholls AJ, Hattersley AT: Solitary functioning kidney and diverse genital tract malformations associated with hepatocyte nuclear factor-lbeta mutations. Kidney Int 2002;61: 1243-1251
11. Schwartz DR, Kardia SL, Shedden KA, Kuick R, Michailidis G, Taylor JM, Misek DE, Wu R, Zhai Y, Darrah DM, Reed H, Ellenson LH, Giordano TJ, Fearon ER, Hanash SM, Cho KR: Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas. Cancer Res 2002;62: 4722-4729
12. Tsuchiya A, Sakamoto M, Yasuda J, Chuma M, Ohta T, Ohki M, Yasugi T, Taketani Y, Hirohashi S: Expression profiling in ovarian clear cell carcinoma: Identification of hepatocyte nuclear factor-lbeta as a molecular marker and a possible molecular target for therapy of ovarian clear cell carcinoma. Am J Pathol 2003;163:2503-2512
13. Lu KH, Patterson AP, Wang L, Marquez RT, Atkinson EN, Baggerly KA, Ramoth LR, Rosen DG, Liu J, Hellstrom I, Smith D, Hartmann L, Fishman D, Berchuck A, Schmandt R, Whitaker R, Gershenson DM, Mills GB, Bast RC Jr: Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis. Clin Cancer Res 2004;10:3291-3300
14. Kato N, Sasou S, Motoyama T: Expression of hepatocyte nuclear factor-lbeta (HNF-lbeta) in clear cell tumors and endometriosis of the ovary. Mod Pathol 2006;19:83-89
15. Yamamoto S, Tsuda H, Aida S, Shimazaki H, Tamai S, Mat-subara O: Immunohistochemical detection of hepatocyte nuclear factor lbeta in ovarian and endometrial clear cell adenocarcinoma and nonneoplastic endometrium. Hum Pathol 2007;38:1074-1080
16. Bellanné-Chantelot C, Chauveau D, Gautier JF, Dubois-Laforgue D, Clauin S, Beaufils S, Wilhelm JM, Boitard C, Noel LH, Velho G, Timsit J: Clinical spectrum associated with hepatocyte nuclear factor-lbeta mutations. Ann Intern Med 2004;140:510-517
17. Edghill EL, Bingham C, Ellard S, Hattersley AT: Mutations in hepatocyte nuclear factor-lbeta and their related pheno-types. J Med Genet 2006;43:84-90
18. Gresh L, Fischer E, Reimann A, Tanguy M, Garbay S, Shao X, Hiesberger T, Fiette L, Igarashi P, Yaniv M, Pontoglio M: A transcriptional network in polycystic kidney disease. EMBO J 2004;23:1657-1668
19. Barbacci E, Chalkiadaki A, Masdeu C, Haumaitre C, Lok-mane L, Loirat C, Cloarec S, Talianidis I, Bellanne-Chantelot C, Cereghini S: HNFlbeta/TCF2 mutations impair transacti-vation potential through altered co-regulator recruitment. Hum Mol Genet 2004;13:3139-3149
20. Dressier GR, Deutsch U, Chowdhury K, Nornes HO, Gruss P: Pax2, a new murine paired-box-containing gene and its expression in the developing excretory system. Development 1990;109:787-795
21. Kuschert S, Rowitch DH, Haenig B, McMahon AP, Kispert A: Characterization of Pax-2 regulatory sequences that direct transgene expression in the Wolffian duct and its derivatives. Dev Biol 2001;229:128-140
22. Robboy SJ, Bernhardt PF, Parmley T: Embryology of the female genital tract and disorders of abnormal sexual development. In Blaustein's Pathology of the Female Genital Tract. Edited by RJ Kurman. Fourth edition. New York, Springer-Verlag, 1994, pp 3-29
23. Ferry JA, Scully RE: Mesonephric remnants, hyperplasia, and neoplasia in the uterine cervix: A study of 49 cases. Am J Surg Pathol 1990;12:1100-1111
24. McCluggage WG, Oliva E, Herrington CS, McBride H, Young RH: CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma. Histopathology 2003;43:144-150